David Hyman
Tracked across 1 events · 6 articles · First seen Apr 06, 2026 · Last active Aug 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Lilly's Chief Medical Officer, who publicly condemned black-market retatrutide sales, reinforcing the company's stance.
Aug 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Hyman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard